Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses in multiple malignancies, we explored whether p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Mei, Yu, Bi, Wenya Linda, Greenwald, Noah F., Du, Ziming, Agar, Nathalie Y. R., Kaiser, Ursula B., Woodmansee, Whitney W., Reardon, David A., Freeman, Gordon J., Fecci, Peter E., Laws, Edward R., Santagata, Sandro, Dunn, Gavin P., Dunn, Ian F.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363530/
https://ncbi.nlm.nih.gov/pubmed/27655724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12088
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares